Last edition
News about Global Pharma
Geneticist Mary Dickinson Joins The Jackson Laboratory as Chief Scientific Officer
In her new role, Dr. Dickinson will spearhead JAX's research endeavors, directing scientific strategy and operations to leverage the institution's unique strengths in genetics and genomics.
Global Pharma | 13/05/2024 | By Abha | 821
Terumo BCT Receives FDA Clearance for Innovative Rika Plasma Donation System with iNomi Nomogram
This development marks a key advancement in plasma collection technology, allowing for the determination of plasma collection volume based on an individual donor's height, weight, and hematocrit level at the time of donation.
Global Pharma | 13/05/2024 | By Abha | 2490
Sanofi Invests EUR 1 Billion in France to Expand its Biomanufacturing Sites
Sanofi has made an investment of more than EUR 1 billion to create new bioproduction capacity at its sites in Vitry-sur-Seine (Val de Marne), Le Trait (Seine-Maritime) and Lyon Gerland (Rhône).
Global Pharma | 13/05/2024 | By Aishwarya | 1458
The Company continues to expect a decision regarding its 510(k) clearance in July 2024.
Global Pharma | 10/05/2024 | By Manvi | 635
Aardvark Therapeutics Secures USD 85 Million Oversubscribed Series C Financing
Aardvark Therapeutics, Inc. has received an USD 85 million oversubscribed Series C financing led by Decheng Capital.
Global Pharma | 10/05/2024 | By Aishwarya | 550
SN Bioscience's SNB-101 Granted FDA Fast Track Designation for Small Cell Lung Cancer Treatment
SNB-101, previously designated as an orphan drug for SCLC and pancreatic cancer, has now received Fast Track designation, signaling a step towards potential commercialization following the completion of phase 2 clinical trials.
Global Pharma | 10/05/2024 | By Abha | 702
WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval
This approval marks a key moment as the world's first EB virus-related mRNA therapeutic cancer vaccine to receive regulatory clearance.
Global Pharma | 10/05/2024 | By Abha | 955
Flagship Pioneering and Metaphore Enter into Research Collaboration with Novo Nordisk
Metaphore Biotechnologies, in partnership with Flagship Pioneering, has inked a research collaboration with Novo Nordisk to develop up to two next-generation therapeutics for obesity management.
Global Pharma | 10/05/2024 | By Aishwarya | 762
Jeffrey Kindler and Alfonso Zulueta Join Lupin Board as Independent Directors
Lupin has announced the appointment of Jeffrey Kindler and Alfonso “Chito” Zulueta as Independent Directors to its Board.
Global Pharma | 10/05/2024 | By Aishwarya | 818
Epitor Therapeutics Unveils CasNano
Epitor Therapeutics announces the creation of CasNano, a groundbreaking ultracompact Cas protein.
Global Pharma | 09/05/2024 | By Manvi | 571
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy